A single dose of hepatitis A vaccine is sufficient to convey rapid immunity, with nearly all subjects developing hepatitis A antibodies ... vaccine with the monovalent hepatitis A and B vaccines.

Delve into the increasingly dynamic landscape of ALS treatment development with thirteen companies advancing candidates in ...

At day 14 postvaccination, mean anti-Vi antibody GMCs were 2.98 µg/mL and ... obtained following concomitant administration of the monovalent vaccines. The subset of 102 subjects in the ...

Another promising area of research involves monoclonal antibodies (mAbs) designed to bind to opioids in the bloodstream, thereby preventing their distribution to the brain and mitigating overdose ...

The halt follows a severe respiratory disease safety signal observed in a July 2024 phase 1 trial of Moderna's mRNA-1345 and mRNA-1365 vaccine candidates.